Market Closed

SCTX
Scribe Therapeutics
$ 16.36
-3.71%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Scribe Therapeutics News

Latest Scribe Therapeutics Stock News & SCTX Headlines

Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences
10 days ago | globenewswire.com
Scribe Therapeutics Inc. (NASDAQ:SCTX) Stock Rated “Moderate Buy” by Wall Street Analysts
2 months ago | defenseworld.net
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
2 months ago | globenewswire.com
Scribe Therapeutics to Participate in Upcoming Investor Conferences
2 months ago | globenewswire.com
Here Are Monday’s Top Wall Street Analyst Research Calls: AGCO Corporation, Deere & Co., Edison International, Lumentum Holdings, PG&E, Sempra Energy, STAG Industrial, Ticketplus, and More
2 months ago | 247wallst.com
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters' Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
4 months ago | globenewswire.com
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
4 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

SCTX
Scribe Therapeutics
$ 16.36
-3.71%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago